Genmab — Oktober 2018
-
det er noget af et længere studie det næste medikament skal ud i, hvis de skal slå dara med samme HR. Du milde himmel, vejen til at slå kombien Dara/Rev er mere end lang
-
jo tak, men så er det jo lige før, at patentet på dara er udløbet, inden dette medikament er nået op gennem linjerne
-
duration vil vel altid være et tema. Det var det ihvertfald for Cart T
-
På dansk og god morgen https://www.nordnet.dk/mux/web/analys/nyheter/visaNyhet.html?itemid=501147013&sourcecode=ddk
-
God morgen.

-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind